Share Price and Basic Stock Data
Last Updated: November 13, 2025, 11:23 pm
| PEG Ratio | 0.36 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Brilliant Portfolios Ltd operates as a Non-Banking Financial Company (NBFC) and has demonstrated steady revenue growth over recent years. The company’s sales for the fiscal year ending March 2022 stood at ₹2.33 Cr, which increased to ₹2.78 Cr in March 2023, and further rose to ₹3.06 Cr in March 2024. The trailing twelve months (TTM) sales reached ₹3.11 Cr, indicating a consistent upward trajectory. Quarterly sales figures reflect this trend, with the latest reported sales of ₹0.75 Cr in December 2023 and projected growth to ₹0.89 Cr by March 2025. The company maintains strong operating margins, with an operating profit margin (OPM) of 83.15%, showcasing its efficiency in managing operational costs amidst increasing revenues. The absence of significant borrowings or reserves indicates a lean operational structure, which may contribute to its profitability. Overall, Brilliant Portfolios’ revenue growth aligns well with its operational efficiency and market positioning within the NBFC sector.
Profitability and Efficiency Metrics
Brilliant Portfolios Ltd has showcased robust profitability metrics, with a net profit of ₹0.57 Cr reported for the fiscal year ending March 2025. The net profit margin stood at 17.19%, reflecting effective cost management strategies. The company’s return on equity (ROE) is recorded at 6.10%, while the return on capital employed (ROCE) is slightly higher at 9.18%, indicating reasonable returns on shareholders’ equity and capital investments. The interest coverage ratio (ICR) of 1.51x illustrates the company’s ability to meet its interest obligations comfortably. Despite a slight decline in operating profit margin to 58.02% in March 2024, it rebounded to 83.15% in March 2025, demonstrating recovery in operational efficiency. Overall, the profitability metrics are favorable, although the company faces challenges in maintaining consistent margins amidst fluctuating expenses and revenues.
Balance Sheet Strength and Financial Ratios
The balance sheet of Brilliant Portfolios Ltd is characterized by a lack of significant borrowings, as indicated by its total debt to equity ratio of 1.92x, reflecting a relatively leveraged position. The company has also reported a price-to-book value (P/BV) ratio of 0.23x, suggesting that its shares are undervalued relative to the book value. The current ratio is stable at 1.21x, indicating sufficient liquidity to cover short-term obligations. Additionally, the cash conversion cycle stands at 0.00 days, which is indicative of efficient cash management and operational processes. The book value per share has increased to ₹29.96 in March 2025 from ₹25.07 in March 2022, signaling a positive trend in net asset value. However, the absence of reserves may limit the company’s financial flexibility in adverse market conditions, posing a risk to its long-term stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Brilliant Portfolios Ltd reflects a significant presence of public shareholders, who hold 52.78% of the shares as of March 2025. Promoter holdings have increased to 47.23%, up from 44.55% in December 2022, indicating growing confidence among the promoters in the company’s future. The number of shareholders rose to 1,065, suggesting increasing interest and participation from investors. However, the fluctuation in promoter holdings, which peaked at 53.88% in March 2025 before declining, may raise concerns regarding stability and control. Additionally, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could signal a lack of broader market confidence. Overall, while the increasing promoter stake is a positive sign, the reliance on public investors without institutional backing represents a potential vulnerability.
Outlook, Risks, and Final Insight
The outlook for Brilliant Portfolios Ltd appears cautiously optimistic, given its strong operational performance and profitability metrics. However, the company’s reliance on public shareholders and the absence of institutional investments may pose risks related to stock volatility and market perception. Additionally, while the company has maintained a zero borrowing strategy, any unexpected economic downturn could limit its operational flexibility. On the positive side, the consistent revenue growth and strong operational margins position the company favorably within the NBFC sector. The potential for expanding its market share and enhancing profitability exists, provided it can attract institutional investors to bolster its capital structure. Overall, while the company has several strengths, it must navigate the outlined risks to sustain its growth trajectory and enhance shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Brilliant Portfolios Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 13.3 Cr. | 1.33 | 1.91/0.89 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 10.6 Cr. | 1.06 | 11.4/1.03 | 31.3 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 454 Cr. | 138 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.0 Cr. | 15.2 | 37.9/15.0 | 10.4 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 41.8 Cr. | 92.9 | 180/90.0 | 22.4 | 238 | 1.08 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 30,347.39 Cr | 468.72 | 55.40 | 522.84 | 0.21% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.61 | 0.61 | 0.64 | 0.74 | 0.78 | 0.74 | 0.74 | 0.75 | 0.81 | 0.74 | 0.83 | 0.74 | 0.89 |
| Expenses | 0.07 | 0.13 | 0.13 | 0.07 | 0.09 | 0.12 | 0.08 | 0.12 | 0.34 | 0.15 | 0.18 | 0.15 | 0.15 |
| Operating Profit | 0.54 | 0.48 | 0.51 | 0.67 | 0.69 | 0.62 | 0.66 | 0.63 | 0.47 | 0.59 | 0.65 | 0.59 | 0.74 |
| OPM % | 88.52% | 78.69% | 79.69% | 90.54% | 88.46% | 83.78% | 89.19% | 84.00% | 58.02% | 79.73% | 78.31% | 79.73% | 83.15% |
| Other Income | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest | 0.50 | 0.36 | 0.38 | 0.41 | 0.59 | 0.40 | 0.40 | 0.47 | 0.46 | 0.40 | 0.43 | 0.41 | 0.47 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit before tax | 0.04 | 0.13 | 0.13 | 0.27 | 0.10 | 0.22 | 0.26 | 0.17 | 0.01 | 0.16 | 0.19 | 0.16 | 0.24 |
| Tax % | 25.00% | 23.08% | 30.77% | 25.93% | 30.00% | 22.73% | 26.92% | 23.53% | 0.00% | 25.00% | 36.84% | 25.00% | 25.00% |
| Net Profit | 0.03 | 0.10 | 0.10 | 0.20 | 0.07 | 0.17 | 0.19 | 0.13 | 0.01 | 0.13 | 0.12 | 0.12 | 0.18 |
| EPS in Rs | 0.10 | 0.32 | 0.32 | 0.64 | 0.23 | 0.55 | 0.61 | 0.42 | 0.03 | 0.42 | 0.39 | 0.39 | 0.58 |
Last Updated: May 31, 2025, 6:38 am
Below is a detailed analysis of the quarterly data for Brilliant Portfolios Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 0.89 Cr.. The value appears strong and on an upward trend. It has increased from 0.74 Cr. (Dec 2024) to 0.89 Cr., marking an increase of 0.15 Cr..
- For Expenses, as of Mar 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.15 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.74 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Dec 2024) to 0.74 Cr., marking an increase of 0.15 Cr..
- For OPM %, as of Mar 2025, the value is 83.15%. The value appears strong and on an upward trend. It has increased from 79.73% (Dec 2024) to 83.15%, marking an increase of 3.42%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Mar 2025, the value is 0.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.41 Cr. (Dec 2024) to 0.47 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Mar 2025, the value is 0.03 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.03 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.24 Cr.. The value appears strong and on an upward trend. It has increased from 0.16 Cr. (Dec 2024) to 0.24 Cr., marking an increase of 0.08 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 25.00%.
- For Net Profit, as of Mar 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Dec 2024) to 0.18 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.58. The value appears strong and on an upward trend. It has increased from 0.39 (Dec 2024) to 0.58, marking an increase of 0.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.52 | 0.05 | 0.41 | 0.99 | 2.36 | 2.09 | 2.26 | 2.35 | 2.33 | 2.78 | 3.06 | 3.21 | 3.11 |
| Expenses | 0.36 | 0.12 | 0.39 | 0.60 | 0.39 | 0.20 | 0.26 | 0.33 | 0.33 | 0.42 | 0.67 | 0.62 | 0.61 |
| Operating Profit | 0.16 | -0.07 | 0.02 | 0.39 | 1.97 | 1.89 | 2.00 | 2.02 | 2.00 | 2.36 | 2.39 | 2.59 | 2.50 |
| OPM % | 30.77% | -140.00% | 4.88% | 39.39% | 83.47% | 90.43% | 88.50% | 85.96% | 85.84% | 84.89% | 78.10% | 80.69% | 80.39% |
| Other Income | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.15 | 0.15 | 0.15 | 0.41 | 1.56 | 1.46 | 1.40 | 1.61 | 1.58 | 1.73 | 1.73 | 1.72 | 1.66 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.10 |
| Profit before tax | 0.01 | -0.22 | -0.12 | -0.02 | 0.40 | 0.42 | 0.59 | 0.46 | 0.42 | 0.63 | 0.66 | 0.75 | 0.75 |
| Tax % | 100.00% | 0.00% | 8.33% | 0.00% | 5.00% | 21.43% | 25.42% | 26.09% | 23.81% | 25.40% | 24.24% | 28.00% | |
| Net Profit | 0.00 | -0.23 | -0.12 | -0.03 | 0.39 | 0.32 | 0.44 | 0.34 | 0.32 | 0.47 | 0.50 | 0.55 | 0.57 |
| EPS in Rs | 0.00 | -0.74 | -0.39 | -0.10 | 1.26 | 1.03 | 1.42 | 1.10 | 1.03 | 1.52 | 1.61 | 1.77 | 1.84 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 47.83% | 75.00% | 1400.00% | -17.95% | 37.50% | -22.73% | -5.88% | 46.88% | 6.38% | 10.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.17% | 1325.00% | -1417.95% | 55.45% | -60.23% | 16.84% | 52.76% | -40.49% | 3.62% |
Brilliant Portfolios Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 7% |
| 3 Years: | 11% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 5% |
| 3 Years: | 20% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 3% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 6% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:46 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49.13 | 219.00 | 26.71 | 18.43 | 4.64 | 5.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 62.93 | 7.30 | 19.21 | ||||||||
| Days Payable | 50.34 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 49.13 | 219.00 | 39.29 | 25.73 | 23.85 | 5.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -7.02 | -365.00 | -80.12 | 99.55 | 176.31 | 1,016.41 | 1,072.39 | 1,054.62 | 990.04 | 607.90 | 384.08 | 440.05 |
| ROCE % | 2.07% | -0.90% | 0.39% | 3.71% | 17.93% | 23.62% | 12.83% | 8.76% | 8.56% | 9.57% | 9.03% | 9.18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.78 | 1.61 | 1.51 | 1.03 | 1.09 |
| Diluted EPS (Rs.) | 1.78 | 1.61 | 1.51 | 1.03 | 1.09 |
| Cash EPS (Rs.) | 2.15 | 1.61 | 1.51 | 1.03 | 1.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.96 | 28.19 | 26.58 | 25.07 | 24.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.96 | 28.19 | 26.58 | 25.07 | 24.04 |
| Revenue From Operations / Share (Rs.) | 10.33 | 9.82 | 8.91 | 7.47 | 7.53 |
| PBDIT / Share (Rs.) | 8.35 | 7.72 | 7.62 | 6.47 | 6.70 |
| PBIT / Share (Rs.) | 7.97 | 7.72 | 7.62 | 6.47 | 6.69 |
| PBT / Share (Rs.) | 2.44 | 2.13 | 2.04 | 1.36 | 1.48 |
| Net Profit / Share (Rs.) | 1.77 | 1.61 | 1.51 | 1.03 | 1.09 |
| PBDIT Margin (%) | 80.81 | 78.62 | 85.49 | 86.72 | 88.96 |
| PBIT Margin (%) | 77.21 | 78.59 | 85.49 | 86.70 | 88.86 |
| PBT Margin (%) | 23.59 | 21.70 | 22.84 | 18.27 | 19.71 |
| Net Profit Margin (%) | 17.19 | 16.38 | 16.92 | 13.76 | 14.45 |
| Return on Networth / Equity (%) | 5.92 | 5.71 | 5.67 | 4.09 | 4.52 |
| Return on Capital Employeed (%) | 19.02 | 17.74 | 17.24 | 17.90 | 7.64 |
| Return On Assets (%) | 1.71 | 1.52 | 1.36 | 1.08 | 1.14 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 2.17 |
| Total Debt / Equity (X) | 1.92 | 2.05 | 2.19 | 1.97 | 2.17 |
| Asset Turnover Ratio (%) | 0.09 | 0.09 | 0.08 | 0.07 | 0.07 |
| Current Ratio (X) | 1.21 | 1.21 | 1.06 | 0.92 | 7.12 |
| Quick Ratio (X) | 1.21 | 1.20 | 1.06 | 0.92 | 7.10 |
| Inventory Turnover Ratio (X) | 90.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1.51 | 1.38 | 1.36 | 1.27 | 1.29 |
| Interest Coverage Ratio (Post Tax) (X) | 1.32 | 1.29 | 1.27 | 1.20 | 1.21 |
| Enterprise Value (Cr.) | 19.72 | 19.96 | 19.96 | 17.31 | 17.92 |
| EV / Net Operating Revenue (X) | 6.16 | 6.55 | 7.22 | 7.47 | 7.68 |
| EV / EBITDA (X) | 7.62 | 8.33 | 8.45 | 8.62 | 8.63 |
| MarketCap / Net Operating Revenue (X) | 0.67 | 0.71 | 0.74 | 0.95 | 0.86 |
| Price / BV (X) | 0.23 | 0.24 | 0.25 | 0.28 | 0.27 |
| Price / Net Operating Revenue (X) | 0.67 | 0.71 | 0.74 | 0.95 | 0.86 |
| EarningsYield | 0.25 | 0.23 | 0.22 | 0.14 | 0.16 |
After reviewing the key financial ratios for Brilliant Portfolios Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 5. It has increased from 1.61 (Mar 24) to 1.78, marking an increase of 0.17.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 5. It has increased from 1.61 (Mar 24) to 1.78, marking an increase of 0.17.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 3. It has increased from 1.61 (Mar 24) to 2.15, marking an increase of 0.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.96. It has increased from 28.19 (Mar 24) to 29.96, marking an increase of 1.77.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.96. It has increased from 28.19 (Mar 24) to 29.96, marking an increase of 1.77.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 10.33. It has increased from 9.82 (Mar 24) to 10.33, marking an increase of 0.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 8.35, marking an increase of 0.63.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.97. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 7.97, marking an increase of 0.25.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 2.44, marking an increase of 0.31.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 2. It has increased from 1.61 (Mar 24) to 1.77, marking an increase of 0.16.
- For PBDIT Margin (%), as of Mar 25, the value is 80.81. This value is within the healthy range. It has increased from 78.62 (Mar 24) to 80.81, marking an increase of 2.19.
- For PBIT Margin (%), as of Mar 25, the value is 77.21. This value exceeds the healthy maximum of 20. It has decreased from 78.59 (Mar 24) to 77.21, marking a decrease of 1.38.
- For PBT Margin (%), as of Mar 25, the value is 23.59. This value is within the healthy range. It has increased from 21.70 (Mar 24) to 23.59, marking an increase of 1.89.
- For Net Profit Margin (%), as of Mar 25, the value is 17.19. This value exceeds the healthy maximum of 10. It has increased from 16.38 (Mar 24) to 17.19, marking an increase of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.92. This value is below the healthy minimum of 15. It has increased from 5.71 (Mar 24) to 5.92, marking an increase of 0.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.02. This value is within the healthy range. It has increased from 17.74 (Mar 24) to 19.02, marking an increase of 1.28.
- For Return On Assets (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has increased from 1.52 (Mar 24) to 1.71, marking an increase of 0.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.92. This value exceeds the healthy maximum of 1. It has decreased from 2.05 (Mar 24) to 1.92, marking a decrease of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. There is no change compared to the previous period (Mar 24) which recorded 0.09.
- For Current Ratio (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 1.21.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.20 (Mar 24) to 1.21, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 90.44. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 90.44, marking an increase of 90.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.51. This value is below the healthy minimum of 3. It has increased from 1.38 (Mar 24) to 1.51, marking an increase of 0.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 3. It has increased from 1.29 (Mar 24) to 1.32, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 19.72. It has decreased from 19.96 (Mar 24) to 19.72, marking a decrease of 0.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.16. This value exceeds the healthy maximum of 3. It has decreased from 6.55 (Mar 24) to 6.16, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 7.62. This value is within the healthy range. It has decreased from 8.33 (Mar 24) to 7.62, marking a decrease of 0.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.67, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 24) to 0.23, marking a decrease of 0.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.67, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has increased from 0.23 (Mar 24) to 0.25, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Brilliant Portfolios Ltd:
- Net Profit Margin: 17.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.02% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.92% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.32
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 4.39 (Industry average Stock P/E: 55.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.92
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 17.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industry not found | Address not found | Contact not found |